SPI
17.391,52
PKT
-153,53
PKT
-0,88
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | Galenica reduce | Vontobel Research | |
| 26.07.12 | Logitech hold | Vontobel Research | |
| 26.07.12 | Temenos buy | Vontobel Research | |
| 26.07.12 | Clariant buy | Vontobel Research | |
| 26.07.12 | Rieter hold | Vontobel Research | |
| 26.07.12 | Autoneum hold | Vontobel Research | |
| 26.07.12 | Temenos neutral | UBS AG | |
| 26.07.12 | Sika hold | Vontobel Research | |
| 26.07.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 26.07.12 | BB Biotech | Close Brothers Seydler Research AG | |
| 25.07.12 | Swatch (I) buy | Deutsche Bank AG | |
| 25.07.12 | Swatch (I) outperform | Credit Suisse Group | |
| 25.07.12 | Clariant hold | ING | |
| 25.07.12 | UBS outperform | Exane-BNP Paribas SA | |
| 25.07.12 | Rieter neutral | Sarasin Research | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | UBS neutral | Nomura | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Swatch (I) buy | UBS AG | |
| 25.07.12 | Roche kaufen | Sarasin Research | |
| 25.07.12 | Ascom buy | UBS AG | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Swiss Re buy | Vontobel Research | |
| 25.07.12 | Rieter hold | Vontobel Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 25.07.12 | Comet buy | Vontobel Research | |
| 25.07.12 | Holcim hold | Vontobel Research | |
| 24.07.12 | Swatch (I) buy | Sarasin Research | |
| 24.07.12 | UBS neutral | Sarasin Research | |
| 24.07.12 | UBS hold | Commerzbank Corp. & Markets | |
| 24.07.12 | ams-OSRAM buy | Vontobel Research | |
| 24.07.12 | Julius Bär equal-weight | Morgan Stanley | |
| 24.07.12 | Swiss Re neutral | Nomura | |
| 24.07.12 | Baloise reduce | Nomura | |
| 24.07.12 | Swiss Life buy | Nomura | |
| 24.07.12 | ALSO hold | Vontobel Research | |
| 24.07.12 | Sulzer buy | Vontobel Research | |
| 24.07.12 | Swatch (I) buy | Vontobel Research | |
| 23.07.12 | Julius Bär buy | Sarasin Research |